Sperling Prostate Center

Category: Prostate Cancer

“I Did It My Way”

One of Frank Sinatra’s most popular songs is “My Way,” and anyone who’s heard him sing it knows how he builds up to those last two syllables: myyyyyy waaay. When I chose medicine as my career path, part of what influenced me was my idealism. I wanted to help people by curing disease and easing keep reading

Quality of Life After Radical Prostatectomy

Suzanne Somers once remarked, “I appreciate health care that gets to the root cause of our symptoms and promotes wellness, rather than the one-size-fits-all drug-based approach to treating disease. I love maintaining an optimal quality of life – naturally.” Ms. Somers’ words capture what we all want: to stay healthy and preserve vitality of body, keep reading

Marketing vs. Research-Based Information

ASCO Connection is the official membership magazine of the American Society for Clinical Oncology (ASCO). In August 2014, the magazine carried an article by ASCO member Joel B. Nelson, MD (Chair of the Department of Urology at University of Pittsburgh). The title was “The Lack of Value for Robot-Assisted Radical Prostatectomy.”[i] Lack of value? That’s keep reading

Equal Access to Prostate Cancer Care

The Reverend Jesse Jackson described the American dream as one big tent: “And on that big tent you have four basic promises: equal protection under the law, equal opportunity, equal access, and fair share.” A new study suggests that when it comes to prostate cancer (PCa), patients do not have equal access to medical care. keep reading

Scan Abuse and How to Avoid It

  Sadly, prostate cancer (PCa) patients with low-risk disease are still being sent for needless diagnostic bone and CT scans. This was the finding of an impressive multi-disciplinary research team from several institutions (U.S. Veterans Administration and various medical and public policy departments within New York University and Yale University). The investigators found that nearly keep reading

Put an End to Overtreatment

“There is increased use of radiotherapy among patients with indolent prostate cancer with limited to no correlation with tumor biology.” This conclusion was reached by a research team out of UCLA after studying the treatment choices of 37,621 patients.[i] In fact, over half (57.9%) of the men were sent for radiation, while 19.1% had a keep reading
WordPress Image Lightbox